Hospital
RCHP - Florence LLC
RCHP - Florence LLC was paid $3.39M by Medicaid between Jan 2018 and Nov 2024, across 87 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoRCHP - FLORENCE LLC
FLORENCE, AL 35630
FLORENCE, AL 35630
33aNPI1477874337assigned 06/15/2010
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.39M
24GClaims175,659
24DCodes billed87
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#22 of 77
Median peer was paid$1.13M
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,607 | $412K | |
| 2019 | 34,633 | $530K | |
| 2020 | 22,290 | $320K | |
| 2021 | 26,907 | $419K | |
| 2022 | 28,732 | $524K | |
| 2023 | 24,860 | $775K | |
| 2024incomplete | 10,630 | $409K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 21,967 | 19,701 | $1.27M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 19,888 | 18,243 | $743K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 2,289 | 2,003 | $573K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 24,220 | 21,601 | $184K |
| 80053 | Comprehensive metabolic panel | 5.1% | 19,259 | 17,296 | $174K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 2,094 | 1,970 | $47K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 2,131 | 1,998 | $45K |
| 81001 | 1.2% | 11,849 | 10,670 | $41K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 681 | 618 | $32K |
| 87088 | <1% | 2,511 | 2,285 | $26K | |
| 86703 | <1% | 1,036 | 947 | $19K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,144 | 1,102 | $16K |
75 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,889 | $16K |
| 87400 | <1% | 3,313 | $15K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,121 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 882 | $14K |
| 86762 | <1% | 704 | $13K | |
| 86592 | <1% | 2,185 | $12K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,133 | $12K |
| 97597 | <1% | 989 | $11K | |
| 87340 | <1% | 813 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 725 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 844 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 535 | $6K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 150 | $6K |
| 86803 | <1% | 339 | $6K | |
| 84480 | <1% | 300 | $5K | |
| 86850 | <1% | 768 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 568 | $4K |
| 59025 | Fetal non-stress test | <1% | 959 | $4K |
| 81025 | <1% | 1,419 | $4K | |
| 83690 | <1% | 665 | $4K | |
| 84439 | <1% | 380 | $4K | |
| 82607 | <1% | 227 | $3K | |
| 80061 | Lipid panel | <1% | 216 | $3K |
| 86756 | <1% | 178 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 52 | $2K |
| 86900 | <1% | 755 | $2K | |
| 86901 | <1% | 755 | $2K | |
| 43235 | <1% | 32 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 66 | $2K |
| 84484 | <1% | 246 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,560 | $1K |
| 86787 | <1% | 52 | $1K | |
| G0378 | Hospital observation service, per hour | <1% | 26 | $1K |
| 87081 | <1% | 143 | $1K | |
| 85027 | <1% | 230 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 148 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 35 | $997.50 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,067 | $997.50 |
| 83735 | <1% | 169 | $957.18 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 27,237 | $622.23 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 799 | $615.04 |
| 0002A | <1% | 17 | $600.00 | |
| 86480 | <1% | 14 | $548.24 | |
| 82950 | <1% | 76 | $509.17 | |
| 83605 | <1% | 66 | $414.77 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 40 | $402.50 |
| 0001A | <1% | 16 | $393.88 | |
| 85379 | <1% | 64 | $381.82 | |
| 83880 | <1% | 17 | $370.70 | |
| 86141 | <1% | 34 | $368.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 753 | $284.27 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 221 | $283.28 |
| 82553 | <1% | 23 | $221.13 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 55 | $213.82 |
| 82550 | <1% | 37 | $211.20 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 450 | $193.78 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 13 | $187.30 |
| 86812 | <1% | 14 | $184.85 | |
| 86709 | <1% | 14 | $132.64 | |
| 86706 | <1% | 14 | $116.40 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 44 | $110.37 |
| 85652 | <1% | 35 | $108.05 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 31 | $107.84 |
| 86704 | <1% | 14 | $102.56 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 38 | $99.45 |
| 85610 | <1% | 35 | $98.09 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 53 | $97.32 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 12 | $80.04 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 309 | $62.28 |
| 84479 | <1% | 16 | $59.07 | |
| 85730 | <1% | 35 | $49.64 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 24 | $0.48 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 211 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 105 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.